Bloomwell Group

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bloomwell Group - overview

Established

2020

Location

Frankfurt, -, Germany

Primary Industry

Healthcare

About

Bloomwell Group is a Berlin-based company specializing in cannabis-related services, providing innovative solutions to the emerging legal cannabis market in Europe. Its focus lies in improving accessibility and supporting businesses in this evolving sector. Bloomwell Group was founded in 2020 and is headquartered in Frankfurt, Germany. The company focuses on cannabis-related services and has undergone no significant changes in its business operations since inception.


Bloomwell Group was founded by Anna-Sophia Kouparanis, Devin Cuyler, Julian Wichmann, Niklas Kouparanis, and Samuel Menghistu, with Niklas Kouparanis serving as the CEO. It has completed a total of 2 deals, with its most recent investment round being a Seed round on February 7, 2023, led by Measure 8 Venture Partners, raising a total of USD 10. 00 mn. Bloomwell Group primarily provides cannabis-related services designed to cater to businesses operating within the legal cannabis market.


Its offerings focus on improving operational efficiencies and supporting compliance for entities within this sector, particularly as the legalization of cannabis continues to evolve in Europe. The company serves a diverse customer base, which includes businesses involved in cannabis cultivation, distribution, and retail across North America, Europe, and Asia. The company's revenue is generated through subscription models and commercial support services associated with its cannabis-related solutions. Clients engage in various subscription plans that provide access to premium features, technical support, and updates designed to keep them compliant with evolving regulations.


Revenue streams also include partnerships with service providers, enabling integrated solutions tailored to specific operational needs within the cannabis sector. Following its recent funding round in February 2023, Bloomwell Group plans to utilize the USD 10. 00 mn raised to expand its market share in Germany, particularly in light of anticipated cannabis legalization. The funding will support the development of new products aimed at enhancing operational efficiencies for cannabis businesses.


The company's strategy includes targeting the German market specifically while exploring opportunities for growth in other European markets as regulations evolve.


Current Investors

Measure 8 Venture Partners, Voxel, Artemis Growth Partners

Primary Industry

Healthcare

Sub Industries

Healthcare

Website

www.bloomwell.eu

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.